These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 22416982)

  • 1. Pharmacokinetic and pharmacodynamic interaction between nifedipine and metformin in rats: competitive inhibition for metabolism of nifedipine and metformin by each other via CYP isozymes.
    Choi YH; Lee MG
    Xenobiotica; 2012 May; 42(5):483-95. PubMed ID: 22416982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic interaction between itraconazole and metformin in rats: competitive inhibition of metabolism of each drug by each other via hepatic and intestinal CYP3A1/2.
    Choi YH; Lee U; Lee BK; Lee MG
    Br J Pharmacol; 2010 Oct; 161(4):815-29. PubMed ID: 20860661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic interaction between DA-8159, a new erectogenic, and metformin in rats: competitive inhibition of metabolism via hepatic CYP3A1/2.
    Choi YH; Chung SJ; Lee MG
    Br J Pharmacol; 2008 Apr; 153(7):1568-78. PubMed ID: 18204480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic interaction between telithromycin and metformin in diabetes mellitus rats.
    Lee JH; Kang HE; Lee MG
    Xenobiotica; 2010 Mar; 40(3):217-24. PubMed ID: 20039777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of enzyme inducers and inhibitors on the pharmacokinetics of metformin in rats: involvement of CYP2C11, 2D1 and 3A1/2 for the metabolism of metformin.
    Choi YH; Lee MG
    Br J Pharmacol; 2006 Oct; 149(4):424-30. PubMed ID: 16940989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Escherichia coli lipopolysaccharide on the metformin pharmacokinetics in rats.
    Cho YK; Choi YH; Kim SH; Lee MG
    Xenobiotica; 2009 Dec; 39(12):946-54. PubMed ID: 19925384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of the enzyme(s) involved in the metabolism of amiodarone in liver and intestine of rat: the contribution of cytochrome P450 3A isoforms.
    Shayeganpour A; El-Kadi AO; Brocks DR
    Drug Metab Dispos; 2006 Jan; 34(1):43-50. PubMed ID: 16204463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of cysteine on the pharmacokinetics of paclitaxel in rats.
    Lee YK; Han SY; Chin YW; Choi YH
    Arch Pharm Res; 2012 Mar; 35(3):509-16. PubMed ID: 22477198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cytochrome P450 inducers and inhibitors on the pharmacokinetics of intravenous furosemide in rats: involvement of CYP2C11, 2E1, 3A1 and 3A2 in furosemide metabolism.
    Yang KH; Choi YH; Lee U; Lee JH; Lee MG
    J Pharm Pharmacol; 2009 Jan; 61(1):47-54. PubMed ID: 19126296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic interaction between tamoxifen and ondansetron in rats: non-competitive (hepatic) and competitive (intestinal) inhibition of tamoxifen metabolism by ondansetron via CYP2D subfamily and 3A1/2.
    Yang SH; Suh JH; Lee MG
    Cancer Chemother Pharmacol; 2010 Feb; 65(3):407-18. PubMed ID: 19504095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Faster clearance of omeprazole in mutant Nagase analbuminemic rats: possible roles of increased protein expression of hepatic CYP1A2 and lower plasma protein binding.
    Lee DY; Jung YS; Kim YC; Kim SY; Lee MG
    Biopharm Drug Dispos; 2009 Apr; 30(3):107-16. PubMed ID: 19288444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study on altered hepatic metabolism of CYP3A substrates in rats with glycerol-induced acute renal failure.
    Kusaba J; Kajikawa N; Kawasaki H; Kurosaki Y; Aiba T
    Biopharm Drug Dispos; 2012 Jan; 33(1):22-9. PubMed ID: 22351566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of water deprivation on the pharmacokinetics of metformin in rats.
    Choi YH; Lee I; Lee MG
    Biopharm Drug Dispos; 2007 Oct; 28(7):373-83. PubMed ID: 17657786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of enzyme inducers and inhibitors on the pharmacokinetics of intravenous omeprazole in rats.
    Lee DY; Shin HS; Bae SK; Lee MG
    Biopharm Drug Dispos; 2006 Jul; 27(5):209-18. PubMed ID: 16586464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic interaction between metoprolol and SP-8203 in rats: competitive inhibition for the metabolism of metoprolol by SP-8203 via hepatic CYP2D subfamily.
    Han SY; Yoon I; Chin YW; Cho IW; Lee MG; Choi YH
    Xenobiotica; 2012 Oct; 42(10):1017-27. PubMed ID: 22568632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Slower clearance of intravenous metformin in rats with acute renal failure induced by uranyl nitrate: contribution of slower renal and non-renal clearances.
    Choi YH; Lee I; Lee MG
    Eur J Pharm Sci; 2010 Jan; 39(1-3):1-7. PubMed ID: 19454315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereoselective metabolism of cibenzoline, an antiarrhythmic drug, by human and rat liver microsomes: possible involvement of CYP2D and CYP3A.
    Niwa T; Shiraga T; Mitani Y; Terakawa M; Tokuma Y; Kagayama A
    Drug Metab Dispos; 2000 Sep; 28(9):1128-34. PubMed ID: 10950860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of the immunosuppressant tacrolimus in the small intestine: cytochrome P450, drug interactions, and interindividual variability.
    Lampen A; Christians U; Guengerich FP; Watkins PB; Kolars JC; Bader A; Gonschior AK; Dralle H; Hackbarth I; Sewing KF
    Drug Metab Dispos; 1995 Dec; 23(12):1315-24. PubMed ID: 8689938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of dexamethasone on the intestinal first-pass metabolism of indinavir in rats: evidence of cytochrome P-450 3A [correction of P-450 A] and p-glycoprotein induction .
    Lin JH; Chiba M; Chen IW; Nishime JA; deLuna FA; Yamazaki M; Lin YJ
    Drug Metab Dispos; 1999 Oct; 27(10):1187-93. PubMed ID: 10497146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous and oral alfentanil as in vivo probes for hepatic and first-pass cytochrome P450 3A activity: noninvasive assessment by use of pupillary miosis.
    Kharasch ED; Walker A; Hoffer C; Sheffels P
    Clin Pharmacol Ther; 2004 Nov; 76(5):452-66. PubMed ID: 15536460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.